On stability designs in drug shelf-life estimation

Area of Science:

• Pharmaceutical Sciences
• Drug Stability
• Statistical Modeling

Background:

• Determining accurate drug shelf-life is critical for pharmaceutical product quality and patient safety.
• Existing stability designs, such as matrixing and bracketing, have varying efficiencies in shelf-life estimation.
• Optimizing design selection can lead to more precise shelf-life data and potentially reduced development costs.

Purpose of the Study:

• To propose a criterion for selecting the optimal stability design for drug shelf-life determination.
• To provide guidance on choosing between matrixing and bracketing designs based on study objectives.
• To ensure the most precise estimation of drug shelf-life under different constraints.

Main Methods:

• Evaluation of various stability designs including matrixing and bracketing.
• Development of a selection criterion based on the precision of shelf-life estimates.
• Comparative analysis of designs for fixed sample size and fixed precision scenarios.

Main Results:

• For a fixed sample size, the design offering the highest precision in shelf-life estimation is recommended.
• When aiming for a specific level of precision, the design requiring the smallest sample size is identified as optimal.
• An illustrative example demonstrates the practical application of the proposed selection method.

Conclusions:

• The proposed criterion provides a systematic approach to selecting appropriate drug stability designs.
• Optimal design selection enhances the precision of drug shelf-life estimates.
• This methodology supports efficient and reliable drug shelf-life determination in pharmaceutical development.